---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-28T12:19:32.954336'
end_time: '2025-12-28T12:24:09.628500'
duration_seconds: 276.67
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: GSS
  gene_symbol: GSS
  uniprot_accession: P48637
  protein_description: 'RecName: Full=Glutathione synthetase {ECO:0000303|PubMed:7646467};
    Short=GSH synthetase; Short=GSH-S; EC=6.3.2.3 {ECO:0000269|PubMed:7646467, ECO:0000269|PubMed:9215686};
    AltName: Full=Glutathione synthase;'
  gene_info: Name=GSS {ECO:0000312|HGNC:HGNC:4624};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the eukaryotic GSH synthase family.
  protein_domains: Glutathione_synthase. (IPR005615); Glutathione_synthase_a-hlx.
    (IPR014042); Glutathione_synthase_C_euk. (IPR014709); Glutathione_synthase_N_euk.
    (IPR014049); GSH-S_sub-bd_sf. (IPR037013)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 8
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P48637
- **Protein Description:** RecName: Full=Glutathione synthetase {ECO:0000303|PubMed:7646467}; Short=GSH synthetase; Short=GSH-S; EC=6.3.2.3 {ECO:0000269|PubMed:7646467, ECO:0000269|PubMed:9215686}; AltName: Full=Glutathione synthase;
- **Gene Information:** Name=GSS {ECO:0000312|HGNC:HGNC:4624};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the eukaryotic GSH synthase family.
- **Key Domains:** Glutathione_synthase. (IPR005615); Glutathione_synthase_a-hlx. (IPR014042); Glutathione_synthase_C_euk. (IPR014709); Glutathione_synthase_N_euk. (IPR014049); GSH-S_sub-bd_sf. (IPR037013)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "GSS" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'GSS' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **GSS** (gene ID: GSS, UniProt: P48637) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P48637
- **Protein Description:** RecName: Full=Glutathione synthetase {ECO:0000303|PubMed:7646467}; Short=GSH synthetase; Short=GSH-S; EC=6.3.2.3 {ECO:0000269|PubMed:7646467, ECO:0000269|PubMed:9215686}; AltName: Full=Glutathione synthase;
- **Gene Information:** Name=GSS {ECO:0000312|HGNC:HGNC:4624};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the eukaryotic GSH synthase family.
- **Key Domains:** Glutathione_synthase. (IPR005615); Glutathione_synthase_a-hlx. (IPR014042); Glutathione_synthase_C_euk. (IPR014709); Glutathione_synthase_N_euk. (IPR014049); GSH-S_sub-bd_sf. (IPR037013)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "GSS" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'GSS' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **GSS** (gene ID: GSS, UniProt: P48637) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human GSS (glutathione synthetase; UniProt P48637)

Verification of identity and scope
- The human GSS gene encodes glutathione synthetase (EC 6.3.2.3), a homodimeric, ATP-dependent ligase that catalyzes the second and final step of glutathione (GSH) biosynthesis by joining glycine to γ‑glutamyl‑cysteine (γ‑Glu‑Cys) to form GSH. It belongs to the eukaryotic glutathione synthase family, consistent with UniProt P48637 and domain annotations provided (Glutathione_synthase family). This places GSS downstream of glutamate‑cysteine ligase (GCL; GCLC/GCLM) in the GSH pathway (https://doi.org/10.3390/cells12242831, Dec 2023; https://doi.org/10.3390/ijms24098044, Apr 2023) (ikeda2023theemergingroles pages 6-7, fujii2023criticalrolesof pages 4-5).

1) Key concepts and definitions
- Enzymatic function and reaction: GSS catalyzes γ‑Glu‑Cys + glycine + ATP → GSH + ADP + Pi, completing de novo GSH synthesis. This reaction is essential for maintaining the abundant intracellular tripeptide antioxidant GSH (https://doi.org/10.3390/ijms24098044, Apr 2023) (fujii2023criticalrolesof pages 4-5).
- Substrate scope: In addition to glycine, GSS can accept 2‑aminobutyrate as the acceptor, producing ophthalmate (ophthalmic acid), a recognized non‑sulfur GSH analog and biomarker in some redox contexts (https://doi.org/10.3390/cells12242831, Dec 2023) (ikeda2023theemergingroles pages 6-7).
- Cellular context: GSH is synthesized in the cytosol and distributed to organelles (mitochondria, ER, nucleus) via transport systems; the biosynthetic enzymes (GCL, GSS) operate in the cytosol in mammalian cells (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).

2) Reaction specifics, cofactors, and kinetics
- Cofactors and energetics: The ligation by GSS is ATP-dependent; both GCL and GSS use ATP and have low Km values for ATP (low micromolar), supporting function even when cellular energy charge is modest (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).
- Substrate specificity: Physiological substrate is glycine (forming GSH); alternative substrate 2‑aminobutyrate yields ophthalmate, reflecting some promiscuity of the acceptor site (https://doi.org/10.3390/cells12242831, Dec 2023) (ikeda2023theemergingroles pages 6-7).

3) Cellular and tissue localization
- Subcellular localization: GSS functions in the cytosol where de novo GSH synthesis occurs; GSH synthesized in the cytosol is then transported to other compartments. Evidence supports cytosolic synthesis and organellar transport of GSH rather than a distinct organellar biosynthesis step by GSS (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).
- Tissue distribution of GSH (functional context): GSH levels vary widely: plasma ~3.6 μM; erythrocytes ~0.4–3.0 mM; liver up to ~10 mM; astrocytes ~8 mM, illustrating the high-capacity requirement for GSH synthesis in many tissues (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).

4) Pathway context and biological roles
- Pathway: GCL (GCLC/GCLM) forms γ‑Glu‑Cys (rate‑limiting step), and GSS adds glycine to produce GSH. GSH is recycled by glutathione reductase (GSR) using NADPH and serves as cofactor for glutathione peroxidases (GPXs) and glutaredoxins (https://doi.org/10.3390/ijms24098044, Apr 2023; https://doi.org/10.3390/antiox12111953, Nov 2023) (fujii2023criticalrolesof pages 4-5, georgiousiafis2023thekeyrole pages 2-4).
- Ferroptosis and redox homeostasis: Adequate GSH supports GPX4 activity to detoxify lipid peroxides and prevent ferroptotic death; glutathione metabolism intersects with ferroptosis susceptibility and antioxidant defense (https://doi.org/10.3390/cells12242831, Dec 2023) (ikeda2023theemergingroles pages 21-22).

5) Genetic disease: Glutathione synthetase deficiency (GSSD)
- Clinical spectrum: GSSD is a rare autosomal recessive inborn error with presentations ranging from mild (isolated hemolytic anemia) to severe neonatal disease with metabolic acidosis, 5‑oxoprolinuria (L‑5‑oxoproline), and neurological dysfunction. Biochemical signatures include low cellular GSH with elevations in cysteine and γ‑Glu‑Cys in patient fibroblasts, and excess 5‑oxoproline in urine (https://doi.org/10.3390/ijms24098044, Apr 2023; https://doi.org/10.3390/cells12242831, Dec 2023) (fujii2023criticalrolesof pages 4-5, ikeda2023theemergingroles pages 6-7).
- Biomarker pathophysiology: 5‑oxoprolinuria in GSSD is attributed to dysregulated γ‑glutamyl cycle flux; mechanistic discussions include possible 5‑oxoproline formation when γ‑glutamyl intermediates are not efficiently routed to GSH, though certain proposed steps remain hypothetical (https://doi.org/10.3390/cells12242831, Dec 2023) (ikeda2023theemergingroles pages 6-7).
- Genetics: Multiple pathogenic GSS variants have been described; genotype–phenotype relationships remain variably penetrant across cases. The disorder’s rarity and broad spectrum complicate robust frequency estimates (https://doi.org/10.3390/ijms24098044, Apr 2023) (fujii2023criticalrolesof pages 21-22).

6) Regulation of GSS and the GSH biosynthetic system
- Transcriptional control: The rate‑limiting enzyme GCL is regulated by redox‑responsive antioxidant response elements (AREs) via NRF2; this coordinates GSH biosynthesis capacity with oxidative demands. GSS acts in tandem with GCL in the biosynthetic module; pathway‑level control (e.g., cysteine availability, xCT activity) and feedback inhibition on GCL by GSH modulate flux (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).
- Compartmentation and transport: GSH is synthesized in the cytosol and transported to mitochondria and other organelles; SLC transporters and MRPs contribute to distribution and export, integrating GSS output into cellular redox networks (https://doi.org/10.3390/antiox12111953, Nov 2023; https://doi.org/10.3390/cells12242831, Dec 2023) (georgiousiafis2023thekeyrole pages 2-4, ikeda2023theemergingroles pages 21-22).

7) Recent developments (2023–2024 emphasis)
- γ‑glutamyl peptides and ophthalmate: Recent reviews highlight expanding roles of γ‑glutamyl peptides produced by the synthesis system and γ‑glutamyltransferase, including ophthalmate as a product of GSS acting on γ‑Glu‑2‑aminobutyrate, and their potential signaling/biomarker functions (https://doi.org/10.3390/cells12242831, Dec 2023) (ikeda2023theemergingroles pages 6-7).
- Nervous system and cysteine–GSH axis: 2023 overviews emphasize cysteine supply, GSH synthesis, and ferroptosis susceptibility in neuronal contexts, reinforcing GSS’s critical position downstream of GCL (https://doi.org/10.3390/ijms24098044, Apr 2023) (fujii2023criticalrolesof pages 21-22, fujii2023criticalrolesof pages 4-5).
- Ferroptosis linkage: Updated syntheses connect glutathione availability and GPX4 function with ferroptosis control, placing the GCL/GSS module within broader redox–cell death signaling (https://doi.org/10.3390/cells12242831, Dec 2023) (ikeda2023theemergingroles pages 21-22).

8) Applications and implementations
- Diagnostics: In suspected GSSD, diagnostic work‑up includes organic acid analysis demonstrating 5‑oxoproline (pyroglutamate) in urine, cellular/erythrocyte GSH measurement, and confirmatory molecular testing of GSS variants; fibroblast studies demonstrate low GSH with altered precursor pools (https://doi.org/10.3390/ijms24098044, Apr 2023; https://doi.org/10.3390/cells12242831, Dec 2023) (fujii2023criticalrolesof pages 4-5, ikeda2023theemergingroles pages 6-7).
- Therapeutic support: Management strategies derive from pathway biochemistry—antioxidant supplementation and substrate management have been used empirically; pathway modulation often focuses on upstream cysteine availability and GCL activity given rate limitation (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).
- Research tools: Buthionine sulfoximine (BSO) is widely used to inhibit GCL and deplete GSH for mechanistic studies; measurements of GSH/GSSG, γ‑Glu‑Cys, and ophthalmate support flux analysis of the GCL/GSS pathway (https://doi.org/10.3390/antiox12111953, Nov 2023; https://doi.org/10.3390/cells12242831, Dec 2023) (georgiousiafis2023thekeyrole pages 2-4, ikeda2023theemergingroles pages 21-22).

9) Quantitative data and statistics
- Tissue GSH concentrations: Representative values—plasma ~3.6 μM, erythrocytes ~0.4–3.0 mM, liver up to ~10 mM, astrocytes ~8 mM—reflect high flux requirements supported by the GCL/GSS module (https://doi.org/10.3390/antiox12111953, Nov 2023) (georgiousiafis2023thekeyrole pages 2-4).
- Enzymatic parameters: Both GCL and GSS are ATP‑dependent with low micromolar ATP Km; cysteine availability limits flux upstream, with GCL being rate‑limiting for GSH synthesis in many contexts (https://doi.org/10.3390/antiox12111953, Nov 2023; https://doi.org/10.3390/ijms24098044, Apr 2023) (georgiousiafis2023thekeyrole pages 2-4, fujii2023criticalrolesof pages 4-5).
- Disease markers: GSSD biochemical signatures include elevated urinary 5‑oxoproline, reduced cellular GSH, and accumulation of γ‑Glu‑Cys and cysteine in patient cells (https://doi.org/10.3390/ijms24098044, Apr 2023; https://doi.org/10.3390/cells12242831, Dec 2023) (fujii2023criticalrolesof pages 4-5, ikeda2023theemergingroles pages 6-7).

Expert perspective and analysis
- The central role of GSS is mechanistically constrained by upstream cysteine supply and GCL activity, aligning with the observation that therapeutic interventions often target cysteine availability (e.g., via transport or precursors) or NRF2‑dependent transcriptional programs to bolster the entire GSH system. While direct pharmacologic modulation of human GSS is not standard, its product, GSH, gates multiple antioxidant and detoxification processes, and the GCL/GSS axis is a critical choke‑point linking redox state to ferroptosis control through GPX4. In rare GSS deficiency, the pathognomonic 5‑oxoprolinuria underlines the γ‑glutamyl cycle imbalance created when GSS activity is limiting, supporting a diagnostic algorithm centered on organic acid profiling and confirmatory genetics (https://doi.org/10.3390/antiox12111953, Nov 2023; https://doi.org/10.3390/cells12242831, Dec 2023; https://doi.org/10.3390/ijms24098044, Apr 2023) (georgiousiafis2023thekeyrole pages 2-4, ikeda2023theemergingroles pages 6-7, fujii2023criticalrolesof pages 4-5).

Notes on evidence currency and gaps
- The above integrates recent (2023) authoritative reviews consolidating pathway biochemistry, disease phenotypes, and regulatory frameworks. Direct 2024 primary human studies specific to GSS are limited in the provided evidence set; therefore, disease prevalence figures, comprehensive variant catalogs, and detailed human kinetic constants beyond ATP Km are not included and remain areas for targeted literature follow‑up (ikeda2023theemergingroles pages 21-22, fujii2023criticalrolesof pages 21-22).

References

1. (ikeda2023theemergingroles pages 6-7): Yoshitaka Ikeda and Junichi Fujii. The emerging roles of γ-glutamyl peptides produced by γ-glutamyltransferase and the glutathione synthesis system. Cells, 12:2831, Dec 2023. URL: https://doi.org/10.3390/cells12242831, doi:10.3390/cells12242831. This article has 38 citations and is from a poor quality or predatory journal.

2. (fujii2023criticalrolesof pages 4-5): Junichi Fujii, Tsukasa Osaki, Yuya Soma, and Yumi Matsuda. Critical roles of the cysteine–glutathione axis in the production of γ-glutamyl peptides in the nervous system. International Journal of Molecular Sciences, 24:8044, Apr 2023. URL: https://doi.org/10.3390/ijms24098044, doi:10.3390/ijms24098044. This article has 34 citations and is from a poor quality or predatory journal.

3. (georgiousiafis2023thekeyrole pages 2-4): Sofia K. Georgiou-Siafis and Asterios S. Tsiftsoglou. The key role of gsh in keeping the redox balance in mammalian cells: mechanisms and significance of gsh in detoxification via formation of conjugates. Antioxidants, 12:1953, Nov 2023. URL: https://doi.org/10.3390/antiox12111953, doi:10.3390/antiox12111953. This article has 176 citations and is from a poor quality or predatory journal.

4. (ikeda2023theemergingroles pages 21-22): Yoshitaka Ikeda and Junichi Fujii. The emerging roles of γ-glutamyl peptides produced by γ-glutamyltransferase and the glutathione synthesis system. Cells, 12:2831, Dec 2023. URL: https://doi.org/10.3390/cells12242831, doi:10.3390/cells12242831. This article has 38 citations and is from a poor quality or predatory journal.

5. (fujii2023criticalrolesof pages 21-22): Junichi Fujii, Tsukasa Osaki, Yuya Soma, and Yumi Matsuda. Critical roles of the cysteine–glutathione axis in the production of γ-glutamyl peptides in the nervous system. International Journal of Molecular Sciences, 24:8044, Apr 2023. URL: https://doi.org/10.3390/ijms24098044, doi:10.3390/ijms24098044. This article has 34 citations and is from a poor quality or predatory journal.

## Citations

1. fujii2023criticalrolesof pages 4-5
2. ikeda2023theemergingroles pages 6-7
3. georgiousiafis2023thekeyrole pages 2-4
4. ikeda2023theemergingroles pages 21-22
5. fujii2023criticalrolesof pages 21-22
6. https://doi.org/10.3390/cells12242831,
7. https://doi.org/10.3390/ijms24098044,
8. https://doi.org/10.3390/antiox12111953,